Suchergebnisse - "Greil, Richard"

PubPharm (919)

1

Image-Based Consensus Molecular Subtyping in Rectal Cancer Biopsies and Response to Neoadjuvant Chemoradiotherapy

enthalten in: bioRxiv.org | 2024

von Lafarge, M. | Domingo, E. | Sirinukunwattana, K. | +17

2

A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Dorff, T. | Horvath, L. | Autio, K. | +25

3

Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant-ineligible patients with newly diagnosed multiple myeloma

enthalten in: American journal of hematology | 2024

von Ludwig, H. | Melchardt, T. | Sormann, S. | +23

4

Image-based consensus molecular subtyping in rectal cancer biopsies and response to neoadjuvant chemoradiotherapy

enthalten in: NPJ precision oncology | 2024

von Lafarge, M. | Domingo, E. | Sirinukunwattana, K. | +17

5

Cardiac Adverse Events and Remdesivir in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19) : A Post Hoc Safety Analysis of the Randomized DisCoVeRy Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Terzić, V. | Miantezila Basilua, J. | Billard, N. | +123

6

Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412) : a randomised, double-blind, phase 3 trial

enthalten in: The Lancet. Oncology | 2024

von Machiels, J. | Tao, Y. | Licitra, L. | +125

7

Pre-treatment 68 Ga-PSMA-11 PET/CT Prognostic Value in Predicting Response to 177Lu-PSMA-I&T Therapy and Patient Survival

enthalten in: Molecular imaging and biology | 2024

von Eisazadeh, R. | Mirshahvalad, S. | Schwieghofer-Zwink, G. | +6

8

Enhancing anti-CD274 (PD-L1) targeting through combinatorial immunotherapy with bispecific antibodies and fusion proteins : from preclinical to phase II clinical trials

enthalten in: Expert opinion on investigational drugs | 2024

von Kiem, D. | Ocker, M. | Greil, R. | +2

9

Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy) : A phase 3, randomized, double-blind, placebo-controlled trial

enthalten in: The Journal of infection | 2024

von Hites, M. | Lapique, E. | Massonnaud, C. | +84

10

Oncogenic MTOR signaling axis compensates BTK inhibition in a Chronic Lymphocytic Leukemia patient with Richter Transformation : A Case Report and Review of the Literature

enthalten in: Acta haematologica | 2024

von Parigger, T. | Drothler, S. | Scherhäufl, C. | +13

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[92]